查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2022-2029 年自动化细胞成像系统的全球市场
市场调查报告书
商品编码
1166557

2022-2029 年自动化细胞成像系统的全球市场

Global Automatic Cell Imaging System Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

在预测期内 (2022-2029)，自动化细胞成像系统的全球市场规模预计将以 9.1% 的复合年增长率增长。

自动图像分析使用软件从数字图像中分离数据。 算法识别图像中的特定形状和模式，并总结定量信息，用于细胞内结构和功能的细胞成像研究。 这允许动态细胞过程的实时可视化和量化。

市场动态

在预测期内，不断增加的研究活动和来自不同组织的相关资金将推动全球自动化细胞成像系统市场的增长。

不断增加的研究计划和研究成果推动了全球市场的需求。

随着生命科学和生物医学研究的进步，它们变得越来越复杂，需要自动化技术来维持科学进步所需的数据吞吐量。 生物过程的显微成像是生物医学研究中使用的基本数据采集和分析技术。 因此，越来越多的生物医学研究计划和资金正在推动全球自动化细胞成像系统市场的发展。 例如，独立的 ISREC 基金会将重点支持洛桑和瑞士西部的创新癌症研究，特别是转化肿瘤学，这肯定会对癌症患者的未来治疗产生积极影响。我猜。 此外，NCI预计2020年各类慢性病研究预算为64.404亿美元，2024年专业确定预算方案为99.88亿美元。 同样，在 2021 年 7 月，美国非营利组织癌症研究所 (CRI) 宣布，其授予的 2021 年超过美国截至 6 月 30 日的 2021 财年，研究补助金和奖学金为 2850 万美元。 因此，在预测期内，越来越多的生物製药研究计划和发现正在推动自动化细胞成像系统的全球增长。

自动化细胞成像系统的高成本阻碍了自动化细胞成像系统全球市场的增长。

然而，自动化细胞成像系统的高成本预计会阻碍全球市场的增长。 例如，Avantor 表示，根据规格，ImageXpress Pico 自动细胞成像系统的价格在 69,727.58 美元至 81,637.99 美元之间。

COVID-19 影响分析

自 COVID-19 后以来，COVID-19 对全球自动化细胞成像系统市场产生了积极影响，增加了对生物医学研究的投资。 例如，根据非营利性医疗和健康研究倡导组织 Research America 的数据，美国 (U.S.) 的研发 (R&D) 投资将在 2020 年达到 2451 亿美元，比 2019 年增长 11.1%。 2020 年的估计表明公共和私人研发生态系统的增长率发生变化，我们认为这在很大程度上反映了对 COVID-19 大流行的反应和影响。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第四章市场动态

  • 市场影响因素
    • 司机
      • 政府/私营部门的投资
      • 创新与发展
    • 约束因素
      • 自动化细胞成像系统成本高
    • 商机
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按类型

  • 计算机控制类型
  • 触摸屏操作类型

第八章技术

  • 荧光型
  • 发光
  • 相位差
  • 其他

第 9 章按应用

  • 活细胞，体内成像
  • 放映
  • 其他

第 10 章最终用户

  • 医院和诊所
  • 研究所
  • 影像诊断中心

第11章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第12章竞争格局

  • 主要发展和战略
  • 公司股票分析
  • 产品基准

第13章公司简介

  • Thermo Fisher Scientific
    • 公司简介
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • Axion BioSystems
  • Leica Microsystems
  • GE Healthcare Life Sciences
  • Olympus
  • BD
  • BioTek Instruments
  • PerkinElmer Inc.
  • HORIBA Medical
  • Oxford Instruments

第14章 DataM

简介目录
Product Code: DMMD1459

Market Overview

The global automatic cell imaging system market size was valued at US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 9.1% during the forecast period (2022-2029).

Automated image analysis employs software to isolate data from digital images. Algorithms identify specific shapes and patterns in the images and compile quantitative information that is then utilized in cell imaging studies of cellular structure and function in cells. It enables the visualization and quantitation of dynamic cellular processes in real-time.

Market Dynamics

The increasing research activities and related funding from various entities will boost the global automatic cell imaging system market growth during the forecast period.

The increased research initiatives and findings fuel its demand in the global market.

As life sciences and biomedicine studies advance, they become more sophisticated and require automated technology to maintain the data throughput necessary for scientific advancement. Microscopic imaging of biological processes is a fundamental data acquisition and analysis technique used in biomedical research. Therefore, the growing research initiatives and funding in biomedicine boost the global automatic cell imaging system market. For instance, the independent ISREC Foundation focused on supporting innovative cancer research in Lausanne and Western Switzerland, particularly translational oncology that is guaranteed to positively impact the future treatment of cancer patients. Moreover, in 2020 the estimated funding budget for research according to the NCI for various chronic diseases was $6,440.4 million, and the Professional Judgement Budget Proposal for the fiscal year 2024 is $9988 million. Similarly, in July 2021, the Cancer Research Institute (CRI), a U.S. nonprofit organization dedicated to saving more lives through the discovery and development of potent immunotherapies for all cancers, reported that it had awarded more than $28.5 million in research grants and fellowships during the 2021 fiscal year ending June 30, 2021. Thus, the increased research initiatives and findings for biomedicines are boosting the growth of the global automatic cell imaging system during the forecasted period.

The high cost of the automatic cell imaging system will hamper the global automatic cell imaging system market growth.

However, the high cost of the automatic cell imaging system is expected to hamper the global market growth. For instance, according to Avantor, the ImageXpress Pico Automated Cell Imaging System costs from $69,727.58 to $81,637.99 based on the specifications.

COVID-19 Impact Analysis

COVID-19 has positively impacted the global automatic cell imaging system market since post-COVID, and increased investments in biomedical research have been made. For instance, according to Research America, a non-profit medical and health research advocacy association, the United States (U.S.) medical and health research and development (R&D) investment reached $245.1 billion in 2020, an 11.1% increase from 2019. The 2020 estimates suggest changes in growth rates across the public-private sector R&D ecosystem, but it is likely these changes predominantly reflect the reaction to, and effect of, the COVID-19 pandemic.

Segment Analysis

Live cell and in vivo imaging are predicted to dominate the forecast period (2022-2029).

Live cell and in vivo imaging are estimated to hold most of the global automatic cell imaging system market throughout the forecast period (2022-2029) because of the new product introductions by various market payers. For instance, in Oct 2020, CytoSMART Technologies launched Multi Lux, a new automated live-cell imaging system developed for long-term experiments, comparison studies, and large laboratory teams. Similarly, in September 2021, PHC Corporation of North America and Screen Holdings Co., Ltd partnered to market the Screen Cell imager series of live cell imaging systems in North America. Additionally, in April 2022, CytoSMART technologies introduced the Omni FL, a new live-cell imaging analysis system containing red and green fluorescence channels, into its signature Omni product line for the first time. Furthermore, in June 2021, Leica Microsystems introduced its Leica Nano workflow, a brand new live-cell correlative light and electron microscopy (CLEM) workflow solution developed to improve experimental success rates, reproducibility and simplify light and electron microscopy (EM) integration. Thus, the increasing product introduction for live cell and in vivo imaging ensures its dominance over the global automatic cell imaging system market during the forecast period.

Geographical Analysis

The North America region holds the largest global automatic cell imaging system market share.

The North America automatic cell imaging system market is expected to grow at a high CAGR throughout the forecast period, owing to increasing initiatives by the government toward biomedical research. For instance, according to the American Association for the Advancement of Science, Congress created the Advanced Research Projects Agency for Health (ARPA-H), provided around $1 billion for startup investment, and has plans to provide $6.5 billion in funding. Furthermore, most of the key market players, such as Axion BioSystems, BD, BioTek Instruments, and Thermo Fisher Scientific, hold the majority of market share through various market strategies, ensuring the growth of the North America automatic cell imaging systems. For instance, in March 2022, Axion BioSystems, a leading life sciences tools company focused on advanced live-cell assay systems, acquired the Netherlands-based CytoSMART Technologies, an innovator in kinetic live-cell imaging analysis. Thus, the data above indicates that North America will hold most of the global automatic cell imaging systems market throughout the forecasted period (2022-2029).

Competitive Landscape

The automatic cell imaging system market is moderately competitive due to crucial local and global players involved in the research and innovation of new developments. Some of the key players include Axion BioSystems, Leica Microsystems, GE Healthcare Life Sciences, Olympus, BD, BioTek Instruments, PerkinElmer Inc., HORIBA Medical, Oxford Instruments, and Thermo Fisher Scientific. These key players hold the major share of the market through innovations, product launches, collaborations, acquisitions, and alliances. For instance, in May 2020, CytoSMART Technologies introduced a new live-cell imaging system. The CytoSMART Lux2 Duo Kit offers a straightforward, cost-effective solution to researchers carrying out immediate side-by-side comparisons between cell cultures.

ThermoFisher Scientific

Overview:

ThermoFisher is a U.S.-based company founded in 1956. It is the world leader in serving science with annual revenue of approx. $40 billion has industry-leading brands such as Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD.

Product Portfolio:

The product portfolio of ThermoFisher for Automatic Cell Imaging System has EVOS Cell Imaging Systems: EVOS imaging systems contain high-resolution cameras, bright and digitally controlled LED light sources, and automatic software to help capture stunning, publication-quality images in just a few clicks. These fully automated, multichannel fluorescence or brightfield microscopes feature advanced imaging tools to handle time-lapse movies, multiwell plate scanning, image stitching and tiling, and cell counting.

The global automatic cell imaging system market report would provide access to approximately 40 + market data tables, 45 + figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Investments By Government and Private Organizations
      • 4.1.1.2. Innovations and Developments
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost of automatic cell imaging system
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Computer Controlled Type
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Touch Screen Operate Type

8. By Technology

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 8.1.2. Market Attractiveness Index, By Technology
  • 8.2. Fluorescence
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Luminescence
  • 8.4. Phase Contrast
  • 8.5. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Live Cell and In Vivo Imaging
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Screening
  • 9.4. Others

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User Segment
  • 10.2. Hospitals And Clinics
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Research Centers
  • 10.4. Diagnostic Imaging Centers

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking

13. Company Profiles

  • 13.1. Thermo Fisher Scientific
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Axion BioSystems
  • 13.3. Leica Microsystems
  • 13.4. GE Healthcare Life Sciences
  • 13.5. Olympus
  • 13.6. BD
  • 13.7. BioTek Instruments
  • 13.8. PerkinElmer Inc.
  • 13.9. HORIBA Medical
  • 13.10. Oxford Instruments

LIST NOT EXHAUSTIVE

14. DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us